Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Healthy Extracts (HYEX) Common Equity (2016 - 2025)

Healthy Extracts (HYEX) has 11 years of Common Equity data on record, last reported at $24.1 million in Q3 2025.

  • For Q3 2025, Common Equity rose 2896.6% year-over-year to $24.1 million; the TTM value through Sep 2025 reached $24.1 million, up 2896.6%, while the annual FY2024 figure was $410377.0, 59.94% down from the prior year.
  • Common Equity reached $24.1 million in Q3 2025 per HYEX's latest filing, up from $477958.0 in the prior quarter.
  • Across five years, Common Equity topped out at $24.1 million in Q3 2025 and bottomed at $60508.0 in Q1 2025.
  • Average Common Equity over 5 years is $2.4 million, with a median of $1.2 million recorded in 2023.
  • Peak YoY movement for Common Equity: tumbled 88.47% in 2024, then surged 2896.6% in 2025.
  • A 5-year view of Common Equity shows it stood at $2.5 million in 2021, then decreased by 24.25% to $1.9 million in 2022, then crashed by 45.26% to $1.0 million in 2023, then tumbled by 59.94% to $410377.0 in 2024, then skyrocketed by 5763.27% to $24.1 million in 2025.
  • Per Business Quant database, its latest 3 readings for Common Equity were $24.1 million in Q3 2025, $477958.0 in Q2 2025, and $60508.0 in Q1 2025.